Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | HTT | P42858 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8806221 | 0.87 | ALDH1A1 (0.77) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7121916 | 0.83 | SMN1; SMN2 (0.77) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL10013747 | 0.79 | HTT (0.72) | ALDH1A1HTTSMN1; SMN2GAANPSR1 | |
| SCHEMBL3455654 | 0.79 | HTT (1.00) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL218736 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL29686523 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL29956307 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HTTKMT2ASMN1; SMN2GAA | |
| SCHEMBL3758627 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HTTKMT2ASMN1; SMN2GAA | |
| SCHEMBL6459112 | 0.77 | HTT (0.67) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL20267430 | 0.77 | GAA (0.73) | ALDH1A1HTTKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3685231-B1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) | 2026-05-13 | — | — | EP | claimed |
| WO-2024130663-A1 | DUALLY CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-06-27 | — | — | WO | claimed |
| US-20240124621-A1 | CURABLE COMPOSITION AND USE THEREOF | HENKEL AG & CO KGAA (DE) | 2024-04-18 | — | — | US | claimed |
| EP-4341354-A1 | CURABLE COMPOSITION AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2024-03-27 | — | — | EP | claimed |
| EP-4301823-A1 | CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL | Henkel AG & Co. KGaA (DE) | 2024-01-10 | — | — | EP | claimed |
| CN-117377731-A | Curable composition and use thereof | 汉高股份有限及两合公司 | 2024-01-09 | — | — | CN | claimed |
| US-11479620-B2 | 3D printing with polymeric nanogel particles | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2022-10-25 | — | — | US | claimed |
| WO-2022183481-A1 | CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL | HENKEL AG & CO. KGAA (DE) | 2022-09-09 | — | — | WO | claimed |
| US-20200283548-A1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2020-09-10 | — | — | US | claimed |
| US-20090220436-A1 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | LIVING PROOF, INC. (US) | 2009-09-03 | — | — | US | claimed |
| WO-2007127065-A9 | IN SITU POLYMERIZATION FOR HAIR TREATMENT | ANDORA INC (US) | 2008-07-31 | — | — | WO | claimed |
| WO-2007134219-A2 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | LIVING PROOF, INC. (US) | 2007-11-22 | — | — | WO | claimed |
| WO-2007127065-A2 | IN SITU POLYMERIZATION FOR HAIR TREATMENT | LIVING PROOF, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| US-7226957-B1 | Method for producing polymers with controlled molecular weight and end group functionality using photopolymerization in microemulsions | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-06-05 | — | — | US | claimed |
| WO-2005042591-A1 | METHOD FOR PRODUCING POLYMERS WITH CONTROLLED MOLECULAR WEIGHT AND END GROUP FUNCTIONALITY USING PHOTOPOLYMERIZATION IN MICROEMULSIONS | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-05-12 | — | — | WO | claimed |
| EP-3685231-B1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20240425631-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2024-12-26 | — | — | US | disclosed |
| EP-1308493-A2 | Reversible pressure sensitive adhesives based on acrylic block copolymers | tesa AG (DE) | 2003-05-07 | — | — | EP | disclosed |
| EP-1251400-A2 | A photopolymerizable element for use as a flexographic printing plate and a process for preparing the plate from the element | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-10-23 | — | — | EP | disclosed |
| EP-1239329-A2 | A process for making a flexographic printing plate and a photosensitive element for use in the process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220436-A1 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | CUTA, ESD, PFAS | ALDH1A1 695/4885HTT 566/4885KMT2A 1776/4885 |
| US-20240425631-A1 | LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH | PUF60, ACR, UMPS | ALDH1A1 1480/4885HTT 128/4885KMT2A 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.